Skip to main content
. 2024 Jul 1;21(8):3697–3731. doi: 10.1021/acs.molpharmaceut.4c00526

Figure 1.

Figure 1

Simulated concentration versus time profiles (solid line) and observed profiles with %CV (open squares) for oral solution (left panel), initial simulation for the tablet (middle panel), and simulation for the tablet following refinement of the model (right panel).